SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-006818
Filing Date
2014-01-10
Accepted
2014-01-09 17:45:33
Documents
3
Period of Report
2014-01-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d655243d8k.htm 8-K 18872
2 EX-99.1 d655243dex991.htm EX-99.1 10218
3 GRAPHIC g655243g09y43.jpg GRAPHIC 2922
  Complete submission text file 0001193125-14-006818.txt   34780
Mailing Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142 857-242-3700
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 14519575
SIC: 2834 Pharmaceutical Preparations